Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 2/20 | 0.38 |
| ▸ | KCNA5 | P22460 | 7/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.35 |
| ▸ | KCNE1 | P15382 | 2/20 | 0.35 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.30 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1414278 | 0.69 | FDPS (0.41) | FDPSKCNA5CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL7125164 | 0.67 | ALDH1A1 (0.31) | FDPS | |
| SCHEMBL8044936 | 0.65 | FDPS (0.36) | FDPSKCNA5CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL19442063 | 0.64 | CHRNA7 (0.40) | FDPSKCNA5CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL2256328 | 0.64 | FDPS (0.38) | FDPSKCNA5CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL19286390 | 0.64 | SMN1; SMN2 (0.43) | FDPSKCNA5CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL18085480 | 0.64 | CHRNA7 (0.40) | FDPSKCNA5CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL3737772 | 0.64 | — | — | |
| SCHEMBL21973884 | 0.64 | CHRNA7 (0.40) | FDPSKCNA5CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL9669427 | 0.64 | FDPS (0.38) | FDPSKCNA5CYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2924143-A1 | COMPOSITIONS AND METHODS FOR THE DEPOSITION OF SILICON OXIDE FILMS | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2015-09-30 | — | — | EP | claimed |
| US-20250316474-A1 | HIGH MODULUS CARBON DOPED SILICON OXIDE FILM FOR MOLD STACK SCALING SOLUTIONS IN ADVANCED MEMORY APPLICATIONS | LAM RES CORP (US) | 2025-10-09 | — | — | US | disclosed |
| WO-2023225132-A1 | HIGH MODULUS CARBON DOPED SILICON OXIDE FILM FOR MOLD STACK SCALING SOLUTIONS IN ADVANCED MEMORY APPLICATIONS | LAM RESEARCH CORPORATION (US) | 2023-11-23 | — | — | WO | disclosed |
| US-20150275355-A1 | COMPOSITIONS AND METHODS FOR THE DEPOSITION OF SILICON OXIDE FILMS | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2015-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150275355-A1 | COMPOSITIONS AND METHODS FOR THE DEPOSITION OF SILICON OXIDE FILMS | NR4A3, NR4A1, RTN4 | FDPS 4799/4885KCNA5 1800/4885CYP1A2 2388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.